Gagan Harsh Sharma as Managing Director (MD) of Bliss GVS Pharma Limited for three years with effect from 11th May 2021 to 10th May 2024 subject to the approval of members in the ensuing Annual General Meeting. 

Gagan Harsh Sharma has 16 years of experience out of which 12 years is with the pharmaceutical Industry. He is currently designated as Executive Director of the company. 

He has managed multiple Mergers & Acquisitions with varying degrees of participation from initial due diligence to handling acute legal issues. Gagan has successfully created Research & Development (R&D) functions focussing on NDDS with strong focus on product pipeline for the EU/US markets. 

He has proficiency in developing and deploying strategic client relationship management models across emerging and developed markets. He has expertise in managing end to end pharmaceutical formulation Capex projects and expert in lean manufacturing techniques across dosage forms like oral solids, semi solids and injectables with special focus on niche products. 

Gagan Harsh Sharma has built teams and capabilities to manage GMP/Regulatory compliance while addressing ever evolving compliance needs for the formulations business. He is skilled in adopting & applying quality techniques & standards to varied business processes to develop organization wide culture of quality. 

He has hands-on experience in developing HR capabilities among large teams and adept in deploying best in class HR practices for continual improvement. Also has a strong focus on building brands and sustainable revenue streams with clear focus on the bottom line.